The Company has enclosed herewith certificate received from RTA under Reg 74 (5) SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31.03.2025
IPCALAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ipca Laboratories has submitted to the exchanges a quarterly certificate received from its Registrar and Transfer Agent (RTA) as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. This certificate, for the quarter ended 31 March 2025, typically confirms that share certificates received from depositories have been issued or duly dealt with, and that securities have been dematerialised or are held in dematerialised form. The filing is a standard, periodic compliance requirement, not linked to any new financial results, dividend, or business update.
No material impact on shareholders or the stock price. This is a routine regulatory compliance submission carried out every quarter by listed companies, and can be safely ignored by retail investors.